-
Most Recent
Search Results
240 results for dgse
3 Electrical Equipment Stocks to Buy Now
This week, three electrical equipment stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall…
Novavax Stock is Set to Soar in the Year Ahead
The potential rewards in NVAX stock far outweigh the risks as the vaccine maker awaits regulatory approval from the WHO and others.
Moderna Is Ready To Rally After 2-Month Market Correction
MRNA stock is ready to rally once again, as the company gears up to deliver millions of Covid-19 vaccines in 2021 and help end this…
Covid-19 Vaccine Orders Are Piling Up, Moderna Stock Has Room to Grow
With production ramping to 1.4 billion doses and next-gen vaccine in trials, don’t underestimate Covid-19 vaccine upside for MRNA stock.
Why Is GSE Systems (GVP) Stock Up 59% Today?
GSE Systems shares are rocketing higher on Friday despite a lack of news. However, GVP stock is seeing incredibly heavy trading this morning!
Alphabet Should Be on Every Technology Investor’s Radar Now
Skeptics might claim the Google search engine is “dead,” but a dose of common sense should get investors to lean bullish on GOOG stock.
Revelation Biosciences (REVB) Stock Soars 120%
REVB stock is soaring 120%, but no news explains the rally. The firm recently finished dosing patients for a trial of its hay fever drug.
Meet Your New Robot Overlords – Morning Linkfest (June 6)
InvestorPlace’s daily dose of some of the best reads elsewhere on Wall Street. Today’s top stories: robots, goats and junk bonds.
FDA Approves Ecstasy Trials for PTSD Sufferers
The Food and Drug Administration (FDA) has approved clinical trials for ecstasy to treat PTSD sufferers, including police and firefighters.
Novavax Stock Is Poised to Climb Further
NVAX stock seems positioned for further gains with the firm’s vaccine deliveries set to begin in early 2022.
Novavax: Big Market Potential, Meaningful Stock Upside
Even after a 5,690% gain, NVAX stock looks positioned for further upside with the firm’s focus on bringing vaccines to low-income countries.
Pfizer Looks Like Good Value With Its Vaccine Catalyst and Dividend Yield
Pfizer looks like good value with its vaccine catalyst and dividend yield. PFE stock will be 60% higher within several years after the FDA grants…
Moderna Is a Great Investment Despite Short-Term Headwinds
Following the FDA approval of its vaccine, MRNA stock is set to make some big gains on distribution deals across the globe.
3 Electrical Equipment Stocks to Buy Now
Three electrical equipment stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded…
OCGN Stock Alert: Why Is Ocugen Up 20% Today?
With Ocugen receiving a green light to move ahead with a key retinal therapeutic, OCGN stock jumped on the positive implications.
Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today
Covid-19 pharma stocks like NVAX stock and BNTX stock are making headlines as Joe Biden promises to vaccinate 100 million Americans.
Covid-19 Vaccine Dose Delay Spells Even More Trouble for Novavax Stock
Investors might hope that the spread of the Delta variant will boost NVAX stock, but a recent news release is likely to hinder progress.
5 Stocks With Weak Free Cash Flow — RGSE I CCCL CMLS RLJE
This week, these five stocks have the worst ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Poor Free Cash Flow — I CCCL RGSE CMLS RLJE
This week, these five stocks have the worst ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Ugly Free Cash Flow — GBSN I HTZ RGSE CCCL
This week, these five stocks have the worst ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Poor Free Cash Flow — CETC RGSE I CCCL CMLS
This week, these five stocks have the worst ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.
4 – 10 of 240 results
